OncologyOnline.net

Oncology Xagena

Xagena Mappa
Medical Meeting
Xagena Salute
Mediexplorer.it

Search results for "Non-muscle invasive bladder cancer"

The results from an interim analysis of KEYNOTE-057, a phase 2 trial evaluating Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bla ...


Activation of the PD-1 pathway has been implicated in resistance to BCG ( Bacillus Calmette–Guérin ) therapy. Pembrolizumab ( Keytruda ), a checkpoint inhibitor with significant activity in patients ...